Page 131 - 《中国药房》2024年4期
P. 131

察。(3)样本量较小,随访时间较短。研究团队将在后续                              4019-4024.
          药学服务中纳入更多患者开展前瞻性队列研究,设置药                                ZHU M C,YANG Y J,ZHENG C Y,et al. Research pro-
          师管理组与非药师管理组,以进一步明确药师构建的药                                gress  on  self-management  ability  of  patients  with  lower
          学服务模式对 LEAD 患者疾病自我管理能力提升及临                              extremity  arteriosclerosis  obliterans[J].  Chin  Nurs  Res,
          床结局改善的作用。                                               2020,34(22):4019-4024.
                                                             [10]  CORBIN J,STRAUSS A. Unending work and care:ma-
          参考文献
                                                                  naging chronic illness at home[M]. San Francisco:Jossey-
          [ 1 ]  WANG Z W,WANG X,HAO G,et al. A national study of
                                                                  Bass,1988:945.
              the prevalence and risk factors associated with peripheral
                                                             [11]  中华医学会外科学分会血管外科学组. 下肢动脉硬化闭
              arterial  disease  from  China:the  China  hypertension  sur‐
                                                                  塞症诊治指南[J]. 中华普通外科学文献(电子版),2016,
              vey,2012-2015[J]. Int J Cardiol,2019,275:165-170.
                                                                  10(1):1-18.
          [ 2 ]  RUDAN D A,RUDAN I,et al. Comparison of global esti‐
                                                                  Vascular Surgery Group of the Chinese Medical Associa‐
              mates of prevalence and risk factors for peripheral artery
                                                                  tion  Surgery  Branch. Guidelines  for  diagnosis  and  treat‐
              disease in 2000 and 2010:a systematic review and analysis
                                                                  ment of arteriosclerosis obliterans of lower limbs[J]. Chin
              [J]. Lancet,2013,382(9901):1329-1340.
                                                                  Arch Gen Surg Electron Ed,2016,10(1):1-18.
          [ 3 ]  下肢动脉粥样硬化性疾病诊治中国专家建议写作组,中
                                                             [12]  KAATZ S,AHMAD D,SPYROPOULOS A C,et al. Defi‐
              华医学会老年医学分会,中华医学会心血管病学分会,
                                                                  nition of clinically relevant non-major bleeding in studies
              等 . 下肢动脉粥样硬化性疾病诊治中国专家建议:2007
                                                                  of  anticoagulants  in  atrial  fibrillation  and  venous  throm-
              [J]. 中华老年医学杂志,2007,26(10):725-740.
                                                                  boembolic  disease  in  non-surgical  patients:communica‐
              Lower Extremity Atherosclerotic Disease Chinese Expert
                                                                  tion  from  the  SSC  of  the  ISTH[J].  J  Thromb  Haemost,
              Recommendation Writing Group,Chinese Society of Geria-
                                                                  2015,13(11):2119-2126.
              trics,Chinese  Society  of  Cardiovascular  Disease,et  al.
                                                             [13]  CHEN Q C,LI L L,CHEN Q G,et al. Critical appraisal
              The  recommendations  of  the  diagnosis  and  management
                                                                  of international guidelines for the screening and treatment
              for  the  patients  with  lower  extremity  atherosclerotic
                                                                  of asymptomatic peripheral artery disease:a systematic re‐
              disease:2007[J]. Chin J Geriatr,2007,26(10):725-740.
                                                                  view[J]. BMC Cardiovasc Disord,2019,19(1):17.
          [ 4 ]  LAXY M,MIELCK A,HUNGER M,et al. The associa‐
                                                             [14]  HIGASHI Y,MIYATA T,SHIGEMATSU H,et al. Two-
              tion between patient-reported self-management behavior,
                                                                  year  follow-up  of  vascular  events  in  peripheral  arterial
              intermediate  clinical  outcomes,and  mortality  in  patients
                                                                  disease  treated  with  antiplatelet  agents:a  prospective
              with type 2 diabetes:results from the KORA:a study[J].   observational  multicenter  cohort  study:SEASON[J].  Sci
              Diabetes Care,2014,37(6):1604-1612.                 Rep,2017,7(1):6095.
          [ 5 ]  JOVICIC A,HOLROYD-LEDUC J M,STRAUS S E. Ef‐  [15]  李赟,王立新,郭阳,等. 药师参与多学科诊疗的模式探
              fects of self-management intervention on health outcomes   讨及效果评价[J]. 中国药房,2023,34(12):1515-1519.
              of patients with heart failure:a systematic review of ran‐  LI  Y,WANG  L  X,GUO  Y,et  al.  Investigation  of  the
              domized  controlled  trials[J].  BMC  Cardiovasc  Disord,  mode  of  pharmacist  participating  in  multi-disciplinary
              2006,6:43.                                          diagnosis  and  treatment  and  effect  evaluation[J].  China
          [ 6 ]  ALHABIB  S,ALDRAIMLY  M,ALFARHAN  A.  An         Pharm,2023,34(12):1515-1519.
              evolving  role  of  clinical  pharmacists  in  managing  diabe‐  [16]  HEIKKILA K,MITCHELL D C,LOFTUS I M,et al. Im‐
              tes:evidence from the literature[J]. Saudi Pharm J,2016,  proving 1-year outcomes of infrainguinal limb revasculari-
              24(4):441-446.                                      zation:population-based cohort study of 104 000 patients
          [ 7 ]  WANG  J  X,WANG  J,QIU  S  C,et  al.  Pharmaceutical   in England[J]. Circulation,2018,137(18):1921-1933.
              care  program  for  ischemic  stroke  patients:a  randomized   [17]  PARVAR S L,NGO L,DAWSON J,et al. Long-term out‐
              controlled trial[J]. Int J Clin Pharm,2021,43(5):1412-  comes following endovascular and surgical revasculariza‐
              1419.                                               tion  for  peripheral  artery  disease:a  propensity  score-
          [ 8 ]  ÖSTBRING M J,ERIKSSON T,PETERSSON G,et al.       matched analysis[J]. Eur Heart J,2021,43(1):32-40.
              Effects  of  a  pharmaceutical  care  intervention  on  clinical   [18]  KIM  S Y,LEE Y  M,SON Y  J.  Factors  associated  with
              outcomes and patient adherence in coronary heart disease:  self-management after hybrid revascularization in patients
              the  MIMeRiC  randomized  controlled  trial[J].  BMC  Car‐  with peripheral artery disease:a structural equations model
              diovasc Disord,2021,21(1):367.                      [J]. J Adv Nurs,2023,79(1):170-181.
          [ 9 ]  朱梦春,杨玉金,郑春艳,等. 下肢动脉硬化闭塞症病人                                 (收稿日期:2023-07-17  修回日期:2023-12-31)
              自我管理能力的研究进展[J]. 护理研究,2020,34(22):                                                   (编辑:刘明伟)



          中国药房  2024年第35卷第4期                                                 China Pharmacy  2024 Vol. 35  No. 4    · 505 ·
   126   127   128   129   130   131   132   133   134   135   136